Compumedics (ASX:CMP) said earnings before interest, taxes, depreciation and amortization (EBITDA) rose 72% to AU$5.4 million in fiscal 2026, with EBITDA margin increasing to about 9% and net profit after tax returning to profit at AU$200,000, according to a Tuesday Australian bourse filing.
The company said fiscal 2026 revenue was AU$60.3 million, up nearly 19% on fiscal 2025.
The company's shares rose 2% in recent Tuesday trade.